SCHEMBL803741

SCHEMBL803741

COC(=O)c1ccc2c(c1)[C@H](N(C)C(=O)CC1CCCC1)CC2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAMPT P43490 1/20 0.45
ALDH1A1 P00352 3/20 0.40
XBP1 P17861 1/20 0.40
HTT P42858 1/20 0.40
ACHE P22303 4/20 0.39
NR1H4 Q96RI1 1/20 0.37
HCRTR1 O43613 2/20 0.37
HCRTR2 O43614 2/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
ATM Q13315 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
NPC1 O15118 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
HPGD P15428 1/20 0.36
CYP2C19 P33261 1/20 0.36
RAB9A P51151 1/20 0.36
PPM1D O15297 1/20 0.36
DRD3 P35462 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL803230 0.89 MEN1 (0.40) NAMPTALDH1A1XBP1HTTACHE
SCHEMBL803268 0.87 ALDH1A1 (0.42) NAMPTALDH1A1XBP1HTTACHE
SCHEMBL785380 0.87 ALDH1A1 (0.42) NAMPTALDH1A1XBP1HTTACHE
SCHEMBL803205 0.83 HCRTR2 (0.44) ALDH1A1ACHENR1H4HCRTR2SMN1; SMN2
SCHEMBL803555 0.81 ACHE (0.38) NAMPTALDH1A1XBP1HTTACHE
SCHEMBL13131173 0.81 ACHE (0.56) ALDH1A1ACHESMN1; SMN2ATMNPSR1
SCHEMBL803516 0.77 NAMPT (0.52) NAMPTALDH1A1SMN1; SMN2NPSR1NPC1
SCHEMBL485030 0.77 ACHE (0.43) ALDH1A1ACHENPC1HPGDRAB9A
SCHEMBL485031 0.77 ACHE (0.43) ALDH1A1ACHENPC1HPGDRAB9A
SCHEMBL784750 0.76 ALDH1A1 (0.40) ALDH1A1XBP1HTTACHESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
US-8680159-B2 Bradykinin 1 receptor modulating compounds GRUENENTHAL GMBH (DE) 2014-03-25 US disclosed
WO-2012038081-A1 SUBSTITUTED BENZAMIDE COMPOUNDS Grünenthal GmbH (DE) 2012-03-29 WO disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed
US-20120071461-A1 Substituted Benzamide Compounds GRUENENTHAL GMBH (DE) 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071461-A1 Substituted Benzamide Compounds BDKRB1, BDKRB2, HRH2 NAMPT 3344/4885ALDH1A1 1267/4885XBP1 3609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.